Additional file 3: Table S1. of Evaluation of early antimicrobial therapy adaptation guided by the BetaLACTAÂŽ test: a case-control study

Additional file 1: Table S1. of Aspirin for Venous Ulcers: Randomised Trial (AVURT): study protocol for a randomised controlled trial

Helen Tilbrook (3532466)
Rachael Forsythe (3532448)
Debbie Rolfe (3532475)
Laura Clark (331689)
Martin Bland (222260)
Hannah Buckley (318036)
Ian Chetter (3532478)
Liz Cook (2552587)
Jo Dumville (3532469)
Rhian Gabe (462397)
Keith Harding (2293927)
Alison Layton (3532454)
Ellie Lindsay (3532457)
Catriona McDaid (3532463)
Christine Moffatt (3532445)
Ceri Phillips (3417365)
Gerard Stansby (3532451)
Peter Vowden (3532460)
Laurie Williams (1367556)
David Torgerson (462403)
Robert Hinchliffe (3532472)

November 2015

Previous randomised trials investigating aspirin in the treatment of VLU. (DOCX 15 kb

Additional file 3: Table S3. of Time to antibiotic therapy and outcome in bacterial meningitis: a Danish population-based cohort study

Jacob Bodilsen (3366059)
Michael Dalager-Pedersen (513931)
Henrik SchĂ¸nheyder (3439376)
Henrik Nielsen (208947)

August 2016

Time to antibiotic therapy and outcome according to time of day of admission, duration of symptoms, ...

Additional file 1: of Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimerâs disease: study protocol for a randomised controlled trial (ELAD study)

Grazia Femminella (6553430)
Eleni Frangou (6553433)
Sharon Love (6245381)
Gail Busza (6553436)
Clive Holmes (237359)
Craig Ritchie (3531092)
Robert Lawrence (229647)
Brady McFarlane (6553439)
George Tadros (6553442)
Basil Ridha (6553445)
Carol Bannister (6553448)
Zuzana Walker (573075)
Hilary Archer (6553451)
Elizabeth Coulthard (6553454)
Ben Underwood (6553457)
Aparna Prasanna (6553460)
Paul Koranteng (6553463)
Salman Karim (6553466)
Kehinde Junaid (6553469)
Bernadette McGuinness (237354)
Ramin Nilforooshan (5172128)
Ajay Macharouthu (6553472)
Andrew Donaldson (6553475)
Simon Thacker (6553478)
Gregor Russell (6553481)
Naghma Malik (6553484)
Vandana Mate (6553487)
Lucy Knight (6553490)
Sajeev Kshemendran (6553493)
John Harrison (3512513)
David Brooks (5369636)
Anthony Passmore (6553496)
Clive Ballard (89605)
Paul Edison (6398009)

April 2019

SPIRIT 2013 checklist: items addressed in the clinical trial protocol. (DOC 121 kb

Additional file 5: Figure S1. of Evaluation of early antimicrobial therapy adaptation guided by the BetaLACTA® test: a case-control study

Marc Garnier (4177243)
Sacha Rozencwajg (4177231)
Tài Pham (4126480)
Sophie Vimont (305139)
Clarisse Blayau (4177249)
Mehdi Hafiani (4177240)
Jean-Pierre Fulgencio (4177237)
Francis Bonnet (4177246)
Jean-Luc Mainardi (430448)
Guillaume Arlet (305142)
Muriel Fartoukh (55470)
Salah Gallah (4177234)
Christophe Quesnel (288319)

June 2017

Comparison of the antimicrobial therapy-related costs between the conventional strategy (left) and t...

Additional file 2: of Rapid antimicrobial susceptibility testing and Î˛-lactam-induced cell morphology changes of Gram-negative biological threat pathogens by optical screening

Heather McLaughlin (5520263)
David Sue (4726281)

December 2018

Table S1. Î˛-lactam-induced cell morphology changes in susceptible Burkholderia strains. (DOCX 22 kb

Additional file 1: Table S1. of Evaluation of Lactobacillus coryniformis CECT5711 strain as a coadjuvant in a vaccination process: a randomised clinical trial in healthy adults

Noemí Redondo (3619805)
Esther Nova (333621)
Alina Gheorghe (3619802)
Ligia Díaz (3619799)
Aurora Hernández (3619808)
Ascensión Marcos (333630)

January 2017

White blood cells (cells/μL) expressed as mean ± SD at the beginning (V1), after 2 weeks (V2) and af...

Additional file 1: of Effect of β-Lactamase inhibitors on in vitro activity of β-Lactam antibiotics against Burkholderia cepacia complex species

Annelien Everaert (1621549)
Tom Coenye (20880)

November 2016

Biological and geographic origin of all Burkholderia cepacia complex strains used in this study. (PD...

Additional file 3: of Comparison of treatment effect sizes from pivotal and postapproval trials of novel therapeutics approved by the FDA based on surrogate markers of disease: a meta-epidemiological study

Joshua Wallach (4741575)
Oriana Ciani (4485976)
Alison Pease (4991474)
Gregg S. Gonsalves (731654)
Harlan Krumholz (3401270)
Rod Taylor (25312)
Joseph Ross (3435704)

March 2018

Table S1. Pivotal trials with at least one postapproval trial with a patient-relevant outcome. (XLSX...

Additional file 1: of Mechanisms of antimicrobial resistance in Gram-negative bacilli

Ătienne RuppĂŠ (3441341)
Paul-Louis Woerther (2225947)
FranĂ§ois Barbier (3441344)

August 2015

Table S1. Intrinsic beta-lactam resistance in clinically relevant Enterobacteriaceae species. Table ...

Additional file 1: of Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial

Matthew Cheng (5314931)
Alexander Lawandi (5314943)
Guillaume Butler-Laporte (5314937)
Katryn Paquette (5314934)
Todd Lee (5314940)

May 2018

SPIRIT 2013 Checklist: Recommended items to address in a clinical trial protocol and related documen...

Additional file 3: Table S3. of Appropriate initial antibiotic therapy in hospitalized patients with gram-negative infections: systematic review and meta-analysis

Gowri Raman (3421376)
Esther Avendano (3421370)
Samantha Berger (3421373)
Vandana Menon (3421379)

September 2015

Study characteristics and results of economic outcomes. Table S4. Study characteristics and results ...

Additional file 1: of The effect of diabetes mellitus on outcomes of patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus: data from a prospective double-blind clinical trial comparing treatment with linezolid versus vancomycin

Ozlem Equils (254355)
Christopher da Costa (3521204)
Michele Wible (3521207)
Benjamin Lipsky (3490649)

September 2016

Definitions of Clinical and Microbiologic Outcomes. Additional file 1: Table S1. defines the clinica...

Additional file 1: Table S1. of Trends in antimicrobial resistance and empiric antibiotic therapy of bloodstream infections at a general hospital in Mid-Norway: a prospective observational study

Arne Mehl (3508217)
Bjørn Åsvold (3508214)
Angela Kümmel (3620546)
Stian Lydersen (36705)
Julie Paulsen (3508211)
Ingvild Haugan (3711322)
Erik Solligård (83245)
Jan Damås (3508205)
Stig Harthug (3711319)
Tom-Harald Edna (3711325)

February 2017

Number (percent) of bloodstream infection episodes stratified by microbe(s)/microbe group and by pla...

Additional file 1: of Effect of flubendazole on developing stages of Loa loa in vitro and in vivo: a new approach for screening filaricidal agents

Fanny Fombad (3443375)
Abdel Njouendou (3465776)
Patrick Ndongmo (5055257)
Manuel Ritter (104679)
Valerine Chunda (6187655)
Haelly Metuge (6187658)
Narcisse Gandjui (5162303)
Peter Enyong (250438)
Flobert Njiokou (208646)
Achim Hoerauf (65649)
Charles Mackenzie (569442)
Samuel Wanji (216392)

January 2019

Table S1. Average and standard deviation value of the % motility of L3 in presence of tested drugs a...

Additional file 8 of Pharmacokinetics, efficacy and tolerance of cefoxitin in the treatment of cefoxitin-susceptible extended-spectrum beta-lactamase producing Enterobacterales infections in critically ill patients: a retrospective single-center study

Paul Chabert (13886680)
Judith Provoost (10970889)
Sabine Cohen (13886683)
Céline Dupieux-Chabert (13886686)
Laurent Bitker (4664245)
Tristan Ferry (412308)
Sylvain Goutelle (6529430)
Jean-Christophe Richard (26640)

September 2022

Additional file 8: Table S4. Univariate factors associated with the acquisition of cefoxitin-resista...

Additional file 1: Table S1. of Aspirin for Venous Ulcers: Randomised Trial (AVURT): study protocol for a randomised controlled trial

Helen Tilbrook (3532466)
Rachael Forsythe (3532448)
Debbie Rolfe (3532475)
Laura Clark (331689)
Martin Bland (222260)
Hannah Buckley (318036)
Ian Chetter (3532478)
Liz Cook (2552587)
Jo Dumville (3532469)
Rhian Gabe (462397)
Keith Harding (2293927)
Alison Layton (3532454)
Ellie Lindsay (3532457)
Catriona McDaid (3532463)
Christine Moffatt (3532445)
Ceri Phillips (3417365)
Gerard Stansby (3532451)
Peter Vowden (3532460)
Laurie Williams (1367556)
David Torgerson (462403)
Robert Hinchliffe (3532472)

November 2015

Previous randomised trials investigating aspirin in the treatment of VLU. (DOCX 15 kb

Additional file 3: Table S3. of Time to antibiotic therapy and outcome in bacterial meningitis: a Danish population-based cohort study

Jacob Bodilsen (3366059)
Michael Dalager-Pedersen (513931)
Henrik SchĂ¸nheyder (3439376)
Henrik Nielsen (208947)

August 2016

Time to antibiotic therapy and outcome according to time of day of admission, duration of symptoms, ...

Additional file 1: of Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimerâs disease: study protocol for a randomised controlled trial (ELAD study)

Grazia Femminella (6553430)
Eleni Frangou (6553433)
Sharon Love (6245381)
Gail Busza (6553436)
Clive Holmes (237359)
Craig Ritchie (3531092)
Robert Lawrence (229647)
Brady McFarlane (6553439)
George Tadros (6553442)
Basil Ridha (6553445)
Carol Bannister (6553448)
Zuzana Walker (573075)
Hilary Archer (6553451)
Elizabeth Coulthard (6553454)
Ben Underwood (6553457)
Aparna Prasanna (6553460)
Paul Koranteng (6553463)
Salman Karim (6553466)
Kehinde Junaid (6553469)
Bernadette McGuinness (237354)
Ramin Nilforooshan (5172128)
Ajay Macharouthu (6553472)
Andrew Donaldson (6553475)
Simon Thacker (6553478)
Gregor Russell (6553481)
Naghma Malik (6553484)
Vandana Mate (6553487)
Lucy Knight (6553490)
Sajeev Kshemendran (6553493)
John Harrison (3512513)
David Brooks (5369636)
Anthony Passmore (6553496)
Clive Ballard (89605)
Paul Edison (6398009)

April 2019

SPIRIT 2013 checklist: items addressed in the clinical trial protocol. (DOC 121 kb

Additional file 5: Figure S1. of Evaluation of early antimicrobial therapy adaptation guided by the BetaLACTA® test: a case-control study

Marc Garnier (4177243)
Sacha Rozencwajg (4177231)
Tài Pham (4126480)
Sophie Vimont (305139)
Clarisse Blayau (4177249)
Mehdi Hafiani (4177240)
Jean-Pierre Fulgencio (4177237)
Francis Bonnet (4177246)
Jean-Luc Mainardi (430448)
Guillaume Arlet (305142)
Muriel Fartoukh (55470)
Salah Gallah (4177234)
Christophe Quesnel (288319)

June 2017

Comparison of the antimicrobial therapy-related costs between the conventional strategy (left) and t...

Additional file 2: of Rapid antimicrobial susceptibility testing and Î˛-lactam-induced cell morphology changes of Gram-negative biological threat pathogens by optical screening

Heather McLaughlin (5520263)
David Sue (4726281)

December 2018

Table S1. Î˛-lactam-induced cell morphology changes in susceptible Burkholderia strains. (DOCX 22 kb

Additional file 1: Table S1. of Evaluation of Lactobacillus coryniformis CECT5711 strain as a coadjuvant in a vaccination process: a randomised clinical trial in healthy adults

Noemí Redondo (3619805)
Esther Nova (333621)
Alina Gheorghe (3619802)
Ligia Díaz (3619799)
Aurora Hernández (3619808)
Ascensión Marcos (333630)

January 2017

White blood cells (cells/μL) expressed as mean ± SD at the beginning (V1), after 2 weeks (V2) and af...

Additional file 1: of Effect of β-Lactamase inhibitors on in vitro activity of β-Lactam antibiotics against Burkholderia cepacia complex species

Annelien Everaert (1621549)
Tom Coenye (20880)

November 2016

Biological and geographic origin of all Burkholderia cepacia complex strains used in this study. (PD...

Additional file 3: of Comparison of treatment effect sizes from pivotal and postapproval trials of novel therapeutics approved by the FDA based on surrogate markers of disease: a meta-epidemiological study

Joshua Wallach (4741575)
Oriana Ciani (4485976)
Alison Pease (4991474)
Gregg S. Gonsalves (731654)
Harlan Krumholz (3401270)
Rod Taylor (25312)
Joseph Ross (3435704)

March 2018

Table S1. Pivotal trials with at least one postapproval trial with a patient-relevant outcome. (XLSX...

Additional file 1: of Mechanisms of antimicrobial resistance in Gram-negative bacilli

Ătienne RuppĂŠ (3441341)
Paul-Louis Woerther (2225947)
FranĂ§ois Barbier (3441344)

August 2015

Table S1. Intrinsic beta-lactam resistance in clinically relevant Enterobacteriaceae species. Table ...

Additional file 1: of Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial

Matthew Cheng (5314931)
Alexander Lawandi (5314943)
Guillaume Butler-Laporte (5314937)
Katryn Paquette (5314934)
Todd Lee (5314940)

May 2018

SPIRIT 2013 Checklist: Recommended items to address in a clinical trial protocol and related documen...

Additional file 3: Table S3. of Appropriate initial antibiotic therapy in hospitalized patients with gram-negative infections: systematic review and meta-analysis

Gowri Raman (3421376)
Esther Avendano (3421370)
Samantha Berger (3421373)
Vandana Menon (3421379)

September 2015

Study characteristics and results of economic outcomes. Table S4. Study characteristics and results ...

Additional file 1: of The effect of diabetes mellitus on outcomes of patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus: data from a prospective double-blind clinical trial comparing treatment with linezolid versus vancomycin

Ozlem Equils (254355)
Christopher da Costa (3521204)
Michele Wible (3521207)
Benjamin Lipsky (3490649)

September 2016

Definitions of Clinical and Microbiologic Outcomes. Additional file 1: Table S1. defines the clinica...

Additional file 1: Table S1. of Trends in antimicrobial resistance and empiric antibiotic therapy of bloodstream infections at a general hospital in Mid-Norway: a prospective observational study

Arne Mehl (3508217)
Bjørn Åsvold (3508214)
Angela Kümmel (3620546)
Stian Lydersen (36705)
Julie Paulsen (3508211)
Ingvild Haugan (3711322)
Erik Solligård (83245)
Jan Damås (3508205)
Stig Harthug (3711319)
Tom-Harald Edna (3711325)

February 2017

Number (percent) of bloodstream infection episodes stratified by microbe(s)/microbe group and by pla...

Additional file 1: of Effect of flubendazole on developing stages of Loa loa in vitro and in vivo: a new approach for screening filaricidal agents

Fanny Fombad (3443375)
Abdel Njouendou (3465776)
Patrick Ndongmo (5055257)
Manuel Ritter (104679)
Valerine Chunda (6187655)
Haelly Metuge (6187658)
Narcisse Gandjui (5162303)
Peter Enyong (250438)
Flobert Njiokou (208646)
Achim Hoerauf (65649)
Charles Mackenzie (569442)
Samuel Wanji (216392)

January 2019

Table S1. Average and standard deviation value of the % motility of L3 in presence of tested drugs a...

Additional file 8 of Pharmacokinetics, efficacy and tolerance of cefoxitin in the treatment of cefoxitin-susceptible extended-spectrum beta-lactamase producing Enterobacterales infections in critically ill patients: a retrospective single-center study

Paul Chabert (13886680)
Judith Provoost (10970889)
Sabine Cohen (13886683)
Céline Dupieux-Chabert (13886686)
Laurent Bitker (4664245)
Tristan Ferry (412308)
Sylvain Goutelle (6529430)
Jean-Christophe Richard (26640)

September 2022

Additional file 8: Table S4. Univariate factors associated with the acquisition of cefoxitin-resista...

Additional file 1: Table S1. of Aspirin for Venous Ulcers: Randomised Trial (AVURT): study protocol for a randomised controlled trial

Helen Tilbrook (3532466)
Rachael Forsythe (3532448)
Debbie Rolfe (3532475)
Laura Clark (331689)
Martin Bland (222260)
Hannah Buckley (318036)
Ian Chetter (3532478)
Liz Cook (2552587)
Jo Dumville (3532469)
Rhian Gabe (462397)
Keith Harding (2293927)
Alison Layton (3532454)
Ellie Lindsay (3532457)
Catriona McDaid (3532463)
Christine Moffatt (3532445)
Ceri Phillips (3417365)
Gerard Stansby (3532451)
Peter Vowden (3532460)
Laurie Williams (1367556)
David Torgerson (462403)
Robert Hinchliffe (3532472)

November 2015

Previous randomised trials investigating aspirin in the treatment of VLU. (DOCX 15 kb

Additional file 3: Table S3. of Time to antibiotic therapy and outcome in bacterial meningitis: a Danish population-based cohort study

Jacob Bodilsen (3366059)
Michael Dalager-Pedersen (513931)
Henrik SchĂ¸nheyder (3439376)
Henrik Nielsen (208947)

August 2016

Time to antibiotic therapy and outcome according to time of day of admission, duration of symptoms, ...

Additional file 1: of Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimerâs disease: study protocol for a randomised controlled trial (ELAD study)

Grazia Femminella (6553430)
Eleni Frangou (6553433)
Sharon Love (6245381)
Gail Busza (6553436)
Clive Holmes (237359)
Craig Ritchie (3531092)
Robert Lawrence (229647)
Brady McFarlane (6553439)
George Tadros (6553442)
Basil Ridha (6553445)
Carol Bannister (6553448)
Zuzana Walker (573075)
Hilary Archer (6553451)
Elizabeth Coulthard (6553454)
Ben Underwood (6553457)
Aparna Prasanna (6553460)
Paul Koranteng (6553463)
Salman Karim (6553466)
Kehinde Junaid (6553469)
Bernadette McGuinness (237354)
Ramin Nilforooshan (5172128)
Ajay Macharouthu (6553472)
Andrew Donaldson (6553475)
Simon Thacker (6553478)
Gregor Russell (6553481)
Naghma Malik (6553484)
Vandana Mate (6553487)
Lucy Knight (6553490)
Sajeev Kshemendran (6553493)
John Harrison (3512513)
David Brooks (5369636)
Anthony Passmore (6553496)
Clive Ballard (89605)
Paul Edison (6398009)

April 2019

SPIRIT 2013 checklist: items addressed in the clinical trial protocol. (DOC 121 kb

Additional file 3: Table S1. of Evaluation of early antimicrobial therapy adaptation guided by the BetaLACTAÂŽ test: a case-control study

Abstract

Extracted data

Additional file 3: Table S1. of Evaluation of early antimicrobial therapy adaptation guided by the BetaLACTAÂŽ test: a case-control study

Abstract

Extracted data

Related items

Related items